Literature DB >> 15319566

The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.

Karin Milde-Langosch1, Heike Röder, Birte Andritzky, Bahriye Aslan, Gabriele Hemminger, Anja Brinkmann, Christoph M Bamberger, Thomas Löning, Ana-Maria Bamberger.   

Abstract

Members of the Fos family of AP-1 transcription factors (c-Fos, FosB, FosB2, Fra-1 and Fra-2) are able to form dimers with Jun proteins which bind to the regulatory sequences of target genes. As many proteases involved in tumor invasion are AP-1-regulated, we assumed that Fos family members might be important for invasion of mammary carcinomas. Therefore, we performed transient transfections with expression vectors for c-Fos, FosB, FosB2, Fra-1 and Fra-2, followed by matrigel invasion assays. Fra-1 transfection resulted in a 2-4-fold increase of invasive cells in both cell lines. In a less degree, the invasive potential of MDA-MB231 cells was stimulated by Fra-2, whereas MCF7 invasion was enhanced by c-Fos and FosB. By double-labelling immunocytochemistry, PAI-1 up-regulation was observed in cells transfected with c-Fos, Fra-1 and Fra-2 expression vectors, whereas MMP1 and MMP9 expression was not affected. Results of cotransfection with a MMP9 promoter construct and AP-1 expression vectors do not indicate a direct up-regulation of MMP9 expression by Fos proteins except a positive effect of c-Fos in MCF7 cells. In parallel, expression of Fos family members as determined by Western Blot analysis in 75 mammary carcinomas was correlated with MMP1, MMP9, PAI-1 and uPAR protein levels in the tumors. Interestingly, high FosB levels were significantly associated with MMP1 overexpression, whereas expression of c-Fos and phosphorylated Fra-1 correlated with MMP9 protein levels. Strong Fra-2 expression correlated with high levels of MMP9, PAI-1, the uPA/PAI-1 complex and early recurrence. These data indicate that Fos proteins, especially Fra-1, c-Fos and Fra-2, might be involved in invasion of breast cancer cells. Copyright 2004 Kluwer Academic Publishers

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319566     DOI: 10.1023/B:BREA.0000032982.49024.71

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  41 in total

1.  A crossroad of microRNAs and immediate early genes (IEGs) encoding oncogenic transcription factors in breast cancer.

Authors:  Aldema Sas-Chen; Roi Avraham; Yosef Yarden
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-02-12       Impact factor: 2.673

Review 2.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

3.  Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.

Authors:  L Oliveira-Ferrer; M Kürschner; V Labitzky; D Wicklein; V Müller; G Lüers; U Schumacher; K Milde-Langosch; C Schröder
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-10       Impact factor: 4.553

4.  PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.

Authors:  Edita Aksamitiene; Boris N Kholodenko; Walter Kolch; Jan B Hoek; Anatoly Kiyatkin
Journal:  Cell Signal       Date:  2010-05-12       Impact factor: 4.315

5.  The novel long noncoding RNA AC138128.1 may be a predictive biomarker in gastric cancer.

Authors:  Xiaowan Chen; Jingxu Sun; Yongxi Song; Peng Gao; Junhua Zhao; Xuanzhang Huang; Bo Liu; Huimian Xu; Zhenning Wang
Journal:  Med Oncol       Date:  2014-09-27       Impact factor: 3.064

6.  Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells.

Authors:  Bethtrice Elliott; Ana Cecilia Millena; Lilya Matyunina; Mengnan Zhang; Jin Zou; Guangdi Wang; Qiang Zhang; Nathan Bowen; Vanessa Eaton; Gabrielle Webb; Shadyra Thompson; John McDonald; Shafiq Khan
Journal:  Cancer Lett       Date:  2019-02-11       Impact factor: 8.679

7.  DEAD-box helicase DP103 defines metastatic potential of human breast cancers.

Authors:  Eun Myoung Shin; Hui Sin Hay; Moon Hee Lee; Jen Nee Goh; Tuan Zea Tan; Yin Ping Sen; See Wee Lim; Einas M Yousef; Hooi Tin Ong; Aye Aye Thike; Xiangjun Kong; Zhengsheng Wu; Earnest Mendoz; Wei Sun; Manuel Salto-Tellez; Chwee Teck Lim; Peter E Lobie; Yoon Pin Lim; Celestial T Yap; Qi Zeng; Gautam Sethi; Martin B Lee; Patrick Tan; Boon Cher Goh; Lance D Miller; Jean Paul Thiery; Tao Zhu; Louis Gaboury; Puay Hoon Tan; Kam Man Hui; George Wai-Cheong Yip; Shigeki Miyamoto; Alan Prem Kumar; Vinay Tergaonkar
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

8.  ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex.

Authors:  Zhe Li; Cristina E Tognon; Frank J Godinho; Laura Yasaitis; Hanno Hock; Jason I Herschkowitz; Chris L Lannon; Eunah Cho; Seong-Jin Kim; Roderick T Bronson; Charles M Perou; Poul H Sorensen; Stuart H Orkin
Journal:  Cancer Cell       Date:  2007-12       Impact factor: 31.743

9.  Data recovery and integration from public databases uncovers transformation-specific transcriptional downregulation of cAMP-PKA pathway-encoding genes.

Authors:  Chiara Balestrieri; Lilia Alberghina; Marco Vanoni; Ferdinando Chiaradonna
Journal:  BMC Bioinformatics       Date:  2009-10-15       Impact factor: 3.169

10.  Mechanical strain induces involution-associated events in mammary epithelial cells.

Authors:  Ana Quaglino; Marcelo Salierno; Jesica Pellegrotti; Natalia Rubinstein; Edith C Kordon
Journal:  BMC Cell Biol       Date:  2009-07-17       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.